LilyLink has been selected to enhance maternal diabetes support for rural communities in New Jersey through the US federal Rural Health Transformation programme, utilising remote monitoring and specialist guidance to improve outcomes outside urban centres.
LilyLink says it has been chosen to help expand maternal diabetes care for rural patients in New Jersey under the federal Rural Health Transformation programme, a move the company says will bring specialist support closer to pregnant women outside urban centres.
According to the company, the initiative will link rural health providers, community groups and care centres with remote glucose monitoring, dietitian input, diabetes education specialists and oversight from maternal-fetal medicine doctors. LilyLink said its system pulls data from continuous glucose monitors and connected blood glucose metres into a single platform for clinical review, with the aim of improving coordination between local clinicians and specialists.
The company also said it plans to widen access for underinsured patients and offer multilingual support. Its website describes the service as a gestational diabetes management platform that combines remote monitoring with specialist guidance for clinicians and patients, including automated tracking tools and data summaries that can be incorporated into clinical workflows.
The federal programme underpinning the project is part of a broader effort by the Centres for Medicare & Medicaid Services to improve access, outcomes and infrastructure in rural healthcare. CMS says the $50bn Rural Health Transformation Programme is intended to support states in building more sustainable rural systems, including through new care models, technology and workforce development. New Jersey’s health department has also highlighted the programme as part of its wider rural health strategy.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
